Volume 3, Issue 1 (Spring-Summer 2019)                   J Res Urol 2019, 3(1): 1-4 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Salehipour M, Malekmohamadi F, Amirzargar H. Impact of Liver Function on Serum Level of Prostate Specific Antigen (PSA) in Cirrhotic Patients, Before and After Receiving Liver Transplant. J Res Urol 2019; 3 (1) :1-4
URL: http://urology.umsha.ac.ir/article-1-57-en.html
1- Associate Professor, Urology Department, Namazi Hosoital, Shiraz University of Medical Sciences, Shiraz, Iran, Associate Professor, Urology Department, Namazi Hosoital, Shiraz University of Medical Sciences, Shiraz, Iran
2- Medical Doctor, Medical College, Shiraz University of Medical Sciences, Shiraz, Iran, Medical Doctor, Medical College, Shiraz University of Medical Sciences, Shiraz, Iran
3- Assistant Professor, Urology Department, Children Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran, Assistant Professor, Urology Department, Children Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran , h_amirzargar@sina.tums.ac.ir
Abstract:   (6190 Views)
Background & Objective: Prostate cancer is considered to be the most prevalent malignancy among males. Prostate specific antigen (PSA) is used for screening this malignancy. Serum levels of PSA is influenced by liver function. This study evaluated variations of serum levels of PSA amongst cirrhotic patients, before and after receiving liver transplantation.
Methods: All cirrhotic males older than 45 y/o in the waiting list of liver transplant, were enrolled in the study. After receiving a medical history and checking a total PSA (tPSA), patients who had abnormality were excluded from the study. So, 60 patients who underwent liver transplantation surgery, with a normal 3 month follow up liver function tests (LFT) participated in this study. Thereafter the tPSA level was checked again. Ultimately 30 patients performed the tPSA after a successful liver transplant.
Results: The mean age of these 30 patient was 57, and average tPSA before liver transplant was 0.4 ng/dl (range: 0.07-1.6), and was 1.6 (range: 0.2-7.3) after transplant. Wilcoxon test revealed significant differences between pre and post-transplant PSA levels (P˂0.001, Z= -4.68).
Conclusions: Serum levels of PSA, rises after a successful liver transplant. In cirrhotic patients, PSA levels may not be authentic. In this study, PSA levels rose by 1.2 ng/dl post-transplant. This study revealed that tPSA may be neither reliable nor sensitive enough as a routine screening test for cirrhotic patients; and seems to do the screening there is a need for lower levels comparing to healthy people for the test.
Full-Text [PDF 377 kb]   (1390 Downloads)    
Type of Study: Research | Subject: Urologic oncology
Received: 2018/11/9 | Accepted: 2018/12/15 | Published: 2019/07/15

References
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA: a cancer journal for clinicians.2011;61(2): 69-90. [DOI:10.3322/caac.20107] [PMID]
2. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev V, Schmid H, Zattoni F. Guía de la EAU para el Cáncer de Próstata. Actas Urológicas Españolas 2009; 33(2):113-26. https://doi.org/10.1016/S0210-4806(09)74110-5 [DOI:10.4321/S0210-48062009000200004]
3. Turini M, Redaelli A, Gramegna P, Radice D. Quality of life and economic considerations in the management of prostate cancer. Pharmacoeconomics. 2003;21(8):527-41. [DOI:10.2165/00019053-200321080-00001] [PMID]
4. Herna' ndez J, Thompson IM. Prostate-Specific Antigen: A Review of the Validation of the Most Commonly Used Cancer Biomarker. Cancer.2004;101:894-904. [DOI:10.1002/cncr.20480] [PMID]
5. Getzenberg RH, Partin AW. Prostate Cancer Tumor Markers.In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology. Philadelphia: Saunders-Elsevier; 2012:Chapter 98:2748-62. [DOI:10.1016/B978-1-4160-6911-9.00098-0]
6. Inci M, Rifaioglu MM, Inci M, Celik M, Demir M, Ulutas T, et al. The Investigation of Total PSA, Free PSA, And Free/Total PSA Ratio in Patients With Liver Cirrhosis Patients According to Child-Pugh Score.Urology.2013;81(3):617-22. [DOI:10.1016/j.urology.2012.11.022] [PMID]
7. Vicentini FC, Botelho LAA, Hisano Marcelo, Ebaid GX, Lucon Marcos, Srouqi M. Are Total Prostate-specific Antigen Serum Levels in Cirrhotic Men Different From Those in Normal Men?. Urology.2009;73(5):1032-5. [DOI:10.1016/j.urology.2009.01.015] [PMID]
8. Cetinkaya M, Cetinkaya H, Ulusoy E, Baz S, Memiş A, Yaşa H, et al. Effect of Postnecrotic ana alcoholic hepatic cirrhosis on development of benign prostatic hyperplasia.Prostate.1998;36(2):80-4. https://doi.org/10.1002/(SICI)1097-0045(19980701)36:2<80::AID-PROS2>3.0.CO;2-I [DOI:10.1002/(SICI)1097-0045(19980701)36:23.0.CO;2-I]
9. Williams PB, Eastham JA, Culkin DJ, Mata JA, Venable DD, Sartor O.Influence of Hepatic Function on Serum Levels of Prostate Specific Antigen. The Journal of Urology. 1997;158(5):1867-9. [DOI:10.1016/S0022-5347(01)64149-1]
10. Bo J, Geoffrey WM, David JH. Fffects of Liver Disease and Transplantation on the Human Prostate. Journal of Andrology.1999;20(4):559-65.
11. Thuluvath PJ. Evaluation of Liver Transplant Recipients. Journal of Clinical and Experimental Hepatology.2011;1(3):199-203 [DOI:10.1016/S0973-6883(11)60238-7]
12. Xavier T, Laurence C , Kerem G, Sophie H, Henri B, Arnaud D. Prostate carcinoma in liver transplant recipients : Think about it!. Urologic Oncology: Seminars and Original Investigations.2015;1-5.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Research in Urology

Designed & Developed by : Yektaweb